Presenter: Dr. Louis-Phillipe Boulet, Laval University, Quebec, QC
Moderator: Dr. Krystelle Godbout, Laval University, Quebec, QC

This presentation will review the current literature on clinical and metabolic consequences of frequent or continuous oral corticosteroid use (OCS) in asthma. Methods to avoid the use of OCS and/or minimize their untoward effects will be discussed. Strategies/methods for weaning OCS (procedure and monitoring) in severe asthmatic patients will be reported, including recent studies specifically on how this can be safely done in real-world.  Finally, sustainability of treatment effect post taper in severe eosinophilic asthma patients will be discussed.

Learning Objectives
At the end of the presentation, attendees will be able to:

  • Understand the clinical and metabolic consequences of frequent or continuous OCS use
  • Describe how to avoid OCS or minimize their use
  • Assess how to proceed with OCS withdrawal
  • Describe a real world perspective on how to conduct such OCS reduction safely
  • Understand sustainability of treatment effect post taper in severe eosinophilic asthma patients


CanMEDs Competencies Addressed

Medical Expert, Professional, Scholar

 

This session is co-developed by the Canadian Thoracic Society and AstraZeneca and is planned to achieve scientific integrity, objectivity and balance.